What does Oramed Pharmaceuticals Inc. do?
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions with a technology platform for the oral delivery of therapeutic proteins. It develops ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes. The company has…
What is Oramed Pharmaceuticals Inc.'s P/E and P/B ratio?
Oramed Pharmaceuticals Inc. has a P/E ratio of 1.0 and a P/B ratio of 0.54.
What is Oramed Pharmaceuticals Inc.'s debt-to-equity ratio?
Oramed Pharmaceuticals Inc. has a debt-to-equity ratio of 0.00.
How much does Oramed Pharmaceuticals Inc. owe compared with what it owns?
Oramed Pharmaceuticals Inc. owes $0.14 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Oramed Pharmaceuticals Inc.'s Positivity rank?
Oramed Pharmaceuticals Inc. is ranked #1,542 of 6,774 companies globally and #351 of 4,000 in United States on PositoAI, with a Positivity Score of 22,612.
Does Oramed Pharmaceuticals Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
Oramed Pharmaceuticals Inc. has no active red flags. It has 1 yellow flag (PosiYellow stress signals, 2/10 points): Quarterly report filed late (NT 10-Q).
Where can I read the latest news about Oramed Pharmaceuticals Inc.?
Recent headlines about Oramed Pharmaceuticals Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Oramed Pharmaceuticals Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Oramed Pharmaceuticals Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.